Prevalence of multidrug‐resistant tuberculosis in Latin America and the Caribbean: a systematic review and meta‐analysis

To evaluate the prevalence of multidrug‐resistant tuberculosis (MDR‐TB) in individuals living in Latin America and the Caribbean (LAC).

[1]  M. Pompílio,et al.  A diagnosis of pulmonary tuberculosis and drug resistance among inmates in Mato Grosso do Sul, Brazil. , 2018, Revista da Sociedade Brasileira de Medicina Tropical.

[2]  Vikram Singh,et al.  Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis , 2017, BMC Public Health.

[3]  K. Alene,et al.  Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China , 2017, BMC Infectious Diseases.

[4]  K. Ukwaja,et al.  Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis , 2017, PloS one.

[5]  Claudia Llerena,et al.  [Characterization of clinical isolates of Mycobacterium tuberculosis from HIV positive individuals in Colombia, 2012]. , 2017, Biomedica : revista del Instituto Nacional de Salud.

[6]  T. Robinson,et al.  Sustainable Development Goals , 2016, World Social Report.

[7]  Xuejiao Hu,et al.  Status of drug-resistant tuberculosis in China: A systematic review and meta-analysis. , 2016, American journal of infection control.

[8]  T. Sterling,et al.  Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru , 2016, PloS one.

[9]  Nalin Rastogi,et al.  First insight into the molecular epidemiology of Mycobacterium tuberculosis in Santa Catarina, southern Brazil. , 2016, Tuberculosis.

[10]  Zhouqin Lu,et al.  The Prevalence of Drug-Resistant Tuberculosis in Mainland China: An Updated Systematic Review and Meta-Analysis , 2016, PloS one.

[11]  Carmen Z. Suarez,et al.  Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Tufanaru,et al.  Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data , 2015, International journal of evidence-based healthcare.

[13]  F. Arias,et al.  [Primary resistance to anti tuberculosis drugs in Chile 2011-2012]. , 2015, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[14]  V. Bollela,et al.  Role of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center , 2015, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  P. van der Stuyft,et al.  Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru , 2015, PloS one.

[16]  Nalin Rastogi,et al.  The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru , 2015, PloS one.

[17]  R. Laniado-Laborín,et al.  Primary drug resistance in a region with high burden of tuberculosis. A critical problem. , 2015, Salud publica de Mexico.

[18]  J. Enciso-Moreno,et al.  Description of the population structure and genetic diversity of tuberculosis in Estado de México, a low prevalence setting from Mexico , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[19]  M. Rezadehbashi,et al.  Prevalence of drug-resistant tuberculosis in Iran: systematic review and meta-analysis. , 2014, American journal of infection control.

[20]  S. Bührer-Sékula,et al.  Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  Nalin Rastogi,et al.  A Systematic Follow-Up of Mycobacterium tuberculosis Drug-Resistance and Associated Genotypic Lineages in the French Departments of the Americas over a Seventeen-Year Period , 2014, BioMed research international.

[22]  A. Kritski,et al.  Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil*, ** , 2014, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[23]  L. Rigouts,et al.  Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-eastern part of Lima, Peru , 2013, BMC Infectious Diseases.

[24]  S. Said-Fernández,et al.  A population-based study of first and second-line drug-resistant tuberculosis in a high-burden area of the Mexico/United States border. , 2013, Memorias do Instituto Oswaldo Cruz.

[25]  Nalin Rastogi,et al.  High initial multidrug-resistant tuberculosis rate in Buenaventura, Colombia: a public–private initiative , 2012, European Respiratory Journal.

[26]  Giselle Mota Bastos,et al.  Prevalência de resistência primária em pacientes com tuberculose pulmonar sem fatores de risco conhecidos para resistência primária , 2012 .

[27]  L. Ferrazoli,et al.  A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, São Paulo, Brazil. , 2012, Memorias do Instituto Oswaldo Cruz.

[28]  Marcos Burgos,et al.  Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients , 2012, PLoS medicine.

[29]  Nalin Rastogi,et al.  Multidrug-resistant tuberculosis in Port-au-Prince, Haiti. , 2012, Revista panamericana de salud publica = Pan American journal of public health.

[30]  Alina Llop,et al.  Vigilancia de la resistencia a los fármacos antituberculosos en Cuba, 2000-2009 , 2011 .

[31]  P. van der Stuyft,et al.  High Prevalence of Primary Multidrug Resistant Tuberculosis in Persons with No Known Risk Factors , 2011, PloS one.

[32]  D. Manissero,et al.  Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis , 2011, European Respiratory Journal.

[33]  N. León-Sicairos,et al.  Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[34]  Sonya S. Shin,et al.  Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008 , 2011, Emerging infectious diseases.

[35]  A. Kipnis,et al.  A high prevalence of resistance in new tuberculosis cases of midwestern Brazil. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[36]  R. Centor,et al.  Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis , 2010, PloS one.

[37]  C. Viegas,et al.  Prevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatment. , 2009, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[38]  Julian P T Higgins,et al.  Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales , 2008, Statistics in medicine.

[39]  Claudia Llerena,et al.  Vigilancia de la resistencia del Mycobacterium tuberculosis a los fármacos antituberculosos, Colombia 2004-2005 , 2008 .

[40]  A. Zavascki,et al.  Mycobacterium tuberculosis resistance in HIV-infected patients from a tertiary care teaching hospital in Porto Alegre, southern Brazil. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[41]  A. C. Lemos,et al.  Anti-tuberculosis drug resistance in strains of Mycobacterium tuberculosis isolated from patients in a tertiary hospital in Bahia. , 2007, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[42]  S. Niemann,et al.  Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  Nalin Rastogi,et al.  Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela , 2006, BMC Microbiology.

[44]  D. Haas,et al.  Multidrug-resistant tuberculosis at an HIV testing center in Haiti , 2006, AIDS.

[45]  A. Faustini,et al.  Risk factors for multidrug resistant tuberculosis in Europe: a systematic review , 2005, Thorax.

[46]  E. Waldman,et al.  A population-based study of drug resistance and transmission of tuberculosis in an urban community. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[47]  J. Caminero,et al.  Results of a national study on anti-mycobacterial drug resistance in El Salvador. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[48]  P. Small,et al.  Does DOTS work in populations with drug-resistant tuberculosis? , 2005, The Lancet.

[49]  T. Mariappan,et al.  The physical and chemical stability of anti-tuberculosis fixed-dose combination products under accelerated climatic conditions. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[50]  A. Kritski,et al.  Resistência aos medicamentos anti-tuberculose de cepas de Mycobacterium tuberculosis isoladas de pacientes atendidos em hospital geral de referência para tratamento de AIDS no Rio de Janeiro , 2004 .

[51]  C. A. Moreira,et al.  Resistencia inicial a drogas antituberculosas en Buenaventura, Colombia , 2004 .

[52]  M. Echemendia,et al.  Vigilancia de la resistencia de Mycobacterium tuberculosis a las drogas antituberculosas en Cuba, 1995-1998 , 2004 .

[53]  S. Natal,et al.  [Isoniazid and rifampicin resistance and prior treatment for tuberculosis]. , 2003, Cadernos de saude publica.

[54]  Nalin Rastogi,et al.  Molecular Characterization and Drug Resistance Patterns of Strains of Mycobacterium tuberculosis Isolated from Patients in an AIDS Counseling Center in Port-au-Prince, Haiti: a 1-Year Study , 2003, Journal of Clinical Microbiology.

[55]  O. Dellagostin,et al.  Drug resistance of strains of Mycobacterium tuberculosis isolated in Brazil. , 2001, Microbes and infection.

[56]  T. Kenyon,et al.  Substandard tuberculosis drugs on the global market and their simple detection. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[57]  J. Bates,et al.  A clinic-based molecular epidemiologic study of tuberculosis in Monterrey, Mexico. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[58]  K. Castro,et al.  Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. , 2000, Archives of internal medicine.

[59]  P. Small,et al.  Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico. , 2000, Archives of internal medicine.

[60]  R. Douce,et al.  Anti-tuberculosis drug resistance in two clinics in Ecuador. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[61]  E. Harrow,et al.  Epidemiology and clinical consequences of drug-resistant tuberculosis in a Guatemalan hospital. , 1998, Chest.

[62]  A. Reingold,et al.  Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[63]  L. Riley,et al.  Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. , 1997, Chest.

[64]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[65]  M. Llanés,et al.  Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014. , 2017, MEDICC review.

[66]  K. Verdonck,et al.  Culture and drug susceptibility testing among previously treated tuberculosis patients in the Dominican Republic, 2014. , 2016, Revista panamericana de salud publica = Pan American journal of public health.

[67]  Claudia Llerena,et al.  Tuberculosis y tuberculosis farmacorresistente en personas privadas de la libertad. Colombia, 2010-2012 , 2015 .

[68]  C. Llerena,et al.  [Tuberculosis and drug-resistance tuberculosis in prisoners. Colombia, 2010-2012]. , 2015, Revista de salud publica.

[69]  M. Llanés,et al.  [Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011]. , 2014, Biomedica : revista del Instituto Nacional de Salud.

[70]  L. Ferrazoli,et al.  A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, São Paulo, Brazil , 2012 .

[71]  Giselle Mota Bastos,et al.  Prevalence of primary drug resistance in pulmonary tuberculosis patients with no known risk factors for such. , 2012, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[72]  D. Moher,et al.  Preferred reporting items of systematic review and meta-analyses: the PRISMA statement , 2011 .

[73]  M. Llanés,et al.  [Surveillance of resistance to antitubercular drugs in Cuba, 2000-2009]. , 2011, Revista panamericana de salud publica = Pan American journal of public health.

[74]  A. Kritski,et al.  Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[75]  M. Mercado,et al.  Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[76]  R. Chaisson,et al.  Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[77]  M. Garzon,et al.  [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs]. , 2008, Biomedica : revista del Instituto Nacional de Salud.

[78]  M. Lourenço,et al.  Drug resistance in Mycobacterium tuberculosis strains isolated from sputum samples from symptomatic outpatients: Complexo de Manguinhos, Rio de Janeiro, Brazil. , 2007, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[79]  D. B. Lima,et al.  Drug-resistant Mycobacterium tuberculosis strains isolated at an AIDS reference center general hospital in Rio de Janeiro * , 2004 .

[80]  C. Moreira,et al.  [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia]. , 2004, Biomedica : revista del Instituto Nacional de Salud.

[81]  M. Llanés,et al.  [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998]. , 2004, Biomedica : revista del Instituto Nacional de Salud.

[82]  M. Palaci,et al.  Tuberculosis and drug resistance among patients seen at an AIDS Reference Center in São Paulo, Brazil. , 2001, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[83]  G. Amaya-Tapia,et al.  Primary and acquired resistance of Mycobacterium tuberculosis in Western Mexico. , 2000, Microbial drug resistance.